-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on Perspective Therapeutics, Lowers Price Target to $14

Benzinga·08/11/2026 13:14:55
Listen to the news
Piper Sandler analyst Biren Amin maintains Perspective Therapeutics (AMEX:CATX) with a Overweight and lowers the price target from $16 to $14.